Novel mutational and pathway signatures in relapsed/refractory colorectal cancer patients.

被引：0
|
作者：
Johnson, Benny
Cooke, Laurence
Mahadevan, Daruka
机构：
[1] Univ Tennessee, Ctr Hlth Sci, West Canc Ctr, Memphis, TN 38163 USA
[2] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
[3] West Canc Ctr, Memphis, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.591
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
591
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Enrichment of colibactin-associated mutational signatures in unexplained colorectal polyposis patients
    Terlouw, Diantha
    Boot, Arnoud
    Ducarmon, Quinten R.
    Nooij, Sam
    Suerink, Manon
    van Leerdam, Monique E.
    van Egmond, Demi
    Tops, Carli M.
    Zwittink, Romy D.
    Ruano, Dina
    Langers, Alexandra M. J.
    Nielsen, Maartje
    van Wezel, Tom
    Morreau, Hans
    BMC CANCER, 2024, 24 (01)
  • [22] Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer
    Meropol, NJ
    Sonnichsen, DS
    Birkhofer, MJ
    Ferreira, I
    Noel, D
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (03) : 221 - 226
  • [23] Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients
    Song, Anna
    Eo, Wankyu
    Lee, Sookyung
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (43) : 12410 - 12420
  • [24] Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer
    Neal J. Meropol
    Daryl S. Sonnichsen
    Martin J. Birkhofer
    Irene Ferreira
    Diane Noel
    Cancer Chemotherapy and Pharmacology, 1999, 43 : 221 - 226
  • [25] Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients
    Anna Song
    Wankyu Eo
    Sookyung Lee
    World Journal of Gastroenterology, 2015, (43) : 12410 - 12420
  • [26] Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer
    Neal J. Meropol
    Daryl S. Sonnichsen
    Martin J. Birkhofer
    Irene Ferreira
    Diane Noel
    Cancer Chemotherapy and Pharmacology, 2001, 47 : 282 - 282
  • [27] Mutational signatures in colorectal cancer from 11 countries reveal new insights in early-onset colorectal cancer
    Dos Santos, Wellington
    Diaz-Gay, Marcos
    Moody, Sarah
    Senkin, Sergey
    Abedi-Ardekani, Behnoush
    Kazachkova, Mariya
    Fitzgerald, Stephen
    Cheema, Saamin
    Gaborieau, Valerie
    Wang, Jingwei
    Carreira, Christine
    Cattiaux, Thomas
    Chopard, Priscilia
    Latimer, Calli
    Zaridze, David
    Cox, Riley
    Malekzadeh, Reza
    Ognjanovic, Miodrag
    Sangrajrang, Suleeporn
    Curado, Maria P.
    Reis, Rui M.
    Holcatova, Ivana
    Vaccaro, Carlos
    Swiatkowska, Beata
    Lissowska, Jolanta
    Wiesner, Carolina
    Shibata, Tatsuhiro
    Sangkhathat, Surasak
    Ashton-Prolla, Patricia
    Humphreys, Laura
    Perdomo, Sandra
    de Caravalho, Ana C.
    Stratton, Mike
    Brennan, Paul
    Alexandrov, Ludmil
    CANCER RESEARCH, 2024, 84 (07)
  • [28] The mutational landscape of circulating cell-free DNA to identify neoadjuvant chemotherapy response in colorectal cancer patients.
    Liu, Yanlong
    Wei, Xiaoli
    Shi, Xinying
    Yang, Ying
    Fu, Lili
    Mao, Beibei
    Zhang, Henghui
    Cui, Binbin
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] The signatures of autozygosity among patients with colorectal cancer
    Bacolod, Manny D.
    Schemmann, Gunter S.
    Wang, Shuang
    Shattock, Richard
    Giardina, Sarah F.
    Zeng, Zhaoshi
    Shia, Jinru
    Stengel, Robert F.
    Gerry, Norman
    Hoh, Josephine
    Kirchhoff, Tomas
    Gold, Bert
    Christman, Michael F.
    Offit, Kenneth
    Gerald, William L.
    Notterman, Daniel A.
    Ott, Jurg
    Paty, Philip B.
    Barany, Francis
    CANCER RESEARCH, 2008, 68 (08) : 2610 - 2621
  • [30] Biomarker Signatures Correlate with Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus
    Liu, Yingmiao
    Starr, Mark D.
    Brady, John C.
    Rushing, Christel
    Bulusu, Anuradha
    Pang, Herbert
    Honeycutt, Wanda
    Amara, Anthony
    Altomare, Ivy
    Uronis, Hope E.
    Hurwitz, Herbert I.
    Nixon, Andrew B.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (04) : 1048 - 1056
12345